Literature DB >> 4001847

Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis.

B Strandvik, K Samuelson.   

Abstract

The fasting serum concentrations of primary bile acids were determined in 30 patients with cystic fibrosis, aged 1 to 27 years, and correlated to liver disease. Cholic (fs-C) and chenodeoxycholic (fS-CDC) acids were determined by radioimmunoassays. Two patients had biopsy-proven liver cirrhosis, 13 had portal fibrosis. 8 had minor different pathological changes, and 7 had normal liver morphology. Standard liver function tests were of no help in evaluating liver disease in these patients. Eight patients had increased fS-C and 15 had increased fS-CDC, not correlated to liver morphology. Serum bile acid determination seems to be of no value in evaluating the extent of liver disease in cystic fibrosis. The more frequent and more marked increase of fS-CDC than of fS-C suggests that there is another hepatic clearance of bile acids in CF and/or that intestinal factors have a greater influence on the serum bile acid concentrations in this disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4001847     DOI: 10.3109/00365528509091668

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  2 in total

Review 1.  Current clinical management of hepatic problems in cystic fibrosis.

Authors:  M S Tanner
Journal:  J R Soc Med       Date:  1986       Impact factor: 5.344

2.  Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.

Authors:  J Cotting; M J Lentze; J Reichen
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.